These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9066865)

  • 1. Drug-related morbidity and mortality and the economic impact of pharmaceutical care.
    Johnson JA; Bootman JL
    Am J Health Syst Pharm; 1997 Mar; 54(5):554-8. PubMed ID: 9066865
    [No Abstract]   [Full Text] [Related]  

  • 2. Costs of drug-related morbidity and mortality: enormous and growing rapidly.
    Bates DW
    J Am Pharm Assoc (Wash); 2001; 41(2):156-7. PubMed ID: 11297325
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-related morbidity and mortality: updating the cost-of-illness model.
    Ernst FR; Grizzle AJ
    J Am Pharm Assoc (Wash); 2001; 41(2):192-9. PubMed ID: 11297331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug therapy: the impact of managed care.
    Hopkins J; Siu S; Cawley M; Rudd P
    Adv Pharmacol; 1998; 44():1-32. PubMed ID: 9547883
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of consultant pharmacists in managing drug-related morbidity and mortality at nursing facilities.
    Harrison DL; Bootman JL; Cox ER
    Am J Health Syst Pharm; 1998 Aug; 55(15):1588-94. PubMed ID: 9706185
    [No Abstract]   [Full Text] [Related]  

  • 6. Lower drug prices may trigger increase in cost of services.
    Schwartz R
    Contemp Longterm Care; 1991 Mar; 14(3):22, 76. PubMed ID: 10109431
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrating disease state management and pharmaceutical care for cost-effective quality care.
    Dillon MJ
    Med Interface; 1995 Oct; 8(10):71, 79. PubMed ID: 10152325
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-related morbidity and mortality. A cost-of-illness model.
    Johnson JA; Bootman JL
    Arch Intern Med; 1995 Oct; 155(18):1949-56. PubMed ID: 7575048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services.
    Schneider PJ
    Pharm Pract Manag Q; 1998 Jul; 18(2):32-6. PubMed ID: 10185237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?
    Schneeweiss S; Schöffski O; Selke GW
    Health Policy; 1998 Jun; 44(3):253-60. PubMed ID: 10182296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinated pharmaceutical care assessment program improves clinical outcomes for high-risk elderly patients.
    Rollins G
    Rep Med Guidel Outcomes Res; 2000 Nov; 11(23):5-7. PubMed ID: 11899982
    [No Abstract]   [Full Text] [Related]  

  • 12. Specialty pharmaceuticals: developing a management plan.
    Willcutts D
    Manag Care Q; 2002; 10(4):26-9. PubMed ID: 12561391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients.
    Cowper PA; Weinberger M; Hanlon JT; Landsman PB; Samsa GP; Uttech KM; Schmader KE; Lewis IK; Cohen HJ; Feussner JR
    Pharmacotherapy; 1998; 18(2):327-32. PubMed ID: 9545151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ready or not, here comes medication therapy management!
    J Am Pharm Assoc (2003); 2005; 45(6):646-8, 650, 652. PubMed ID: 16381407
    [No Abstract]   [Full Text] [Related]  

  • 15. Medication therapy management: 10 years of experience in a large integrated health care system.
    Ramalho de Oliveira D; Brummel AR; Miller DB
    J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facing the next challenge of pharmaceutical care: patient noncompliance.
    Bloom DL
    Med Interface; 1996 Nov; 9(11):67-72. PubMed ID: 10162562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic.
    Lobas NH; Lepinski PW; Abramowitz PW
    Am J Hosp Pharm; 1992 Jul; 49(7):1681-8. PubMed ID: 1621723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug effects and their impact on patient care: a review of the problem.
    Burkholder DF
    Drug Intell Clin Pharm; 1979; 13(7-8):421-4. PubMed ID: 10309000
    [No Abstract]   [Full Text] [Related]  

  • 19. Report on an ambulatory clinical pharmacy program and its cost effectiveness.
    Fortner CR; Tarrant J; Felton HF
    Group Health J; 1985; 6(2):3-6. PubMed ID: 10311383
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-related problems and pharmaceutical care: what are they, do they matter, and what's next?
    Hanlon JT; Artz MB
    Med Care; 2001 Feb; 39(2):109-12. PubMed ID: 11176548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.